Corporate Governance
Somaxon’s management and Board of Directors are committed to operating the company in a transparent and ethical manner, with an understanding that effective corporate governance is closely tied to long-term success, for the benefit of all our stakeholders.
Somaxon’s Board of Directors currently has five independent members and three non-independent members. A number of our independent board members are currently serving or have served as members of senior management of other public companies and have served as directors of other public companies. We have three board committees comprised solely of independent directors, each with a different independent director serving as chair of the committee.
Structure of Somaxon’s Board of Directors
 Chairperson |
 Member |
| Director | Type of Director | Audit Committee |
Compensation Committee |
Nominating Committee |
| David F. Hale | Chairman of the Board |  |
|
|
| Richard W. Pascoe | Director, President & Chief Executive Officer |
|
|
|
| Erle T. Mast | Chair of Audit Committee | |
|
|
| Kurt von Emster | Chair of Nominating/Corporate Governance Committee | |
|
|
| Thomas G. Wiggans | Chair of Compensation Committee | |
|
|
| Michael L. Eagle | Director | |
|
|
| Faheem Hasnain | Director | |
|
|
| Terrell A. Cobb | Director | |
|
|
Governance Documents:
- Corporate Governance Guidelines (.pdf)
- Code of Ethics (.pdf)
- Comprehensive Compliance Program (.pdf)
- California Annual Compliance Declaration (.pdf)
Committee Charters:
